Silence Therapeutics plc

SLN·NasdaqGM·Healthcare
Compare
19.80+0.02 (+0.10%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close19.78
Open19.78
Day range19.7519.81
52-week range4.1919.87
Off day high−0.03%
Off 52-week high−0.33%
Volume1.02M
Avg. volume (3M)2.77M
Market cap1.23B
EPS (TTM)-1.29
Forward P/E-52.11
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.34
Shares outstanding62.20M
Short interest5.78% of float
Earnings dateAug 10, 2026 (est.)
Analyst target19.75
Profit margin0.00%

Against its peers

Compare in full ›
SLN ADRX 2257.HK BNTC PMRA.F SRPT
Market cap 1.23B 1.66B 463.71M 323.77M 1.17B 2.01B
P/E (TTM) — — — — 17.3 —
Forward P/E -52.1 -9.9 — -1.0 — 7.8
Price/book 24.3 -0.7 -9.5 1.8 5.0 1.3
Dividend yield — — — — 1.54% —
1-year change +216.99% −22.69% −51.51% −46.77% −9.28% +7.65%
Today +0.10% −7.02% −0.12% +10.48% +6.01% +2.43%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All SLN news ›
BioSpace·Positive

Merck KGaA makes noise in hematology with $1.1B Silence buy

Germany’s Merck KGaA is making a commotion in the rare disease space with the $1.1 billion acquisition of RNA specialist Silence Therapeutics and the biotech’s Phase 3 asset for polycythemia vera divesiran. The deal gives Merck KGaA “an…

MarketScreener··6 outletsPositive

Germany's Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion

Published on 10/19/2026 at 08:45 am EDT Germany's Merck KGaA said it agreed to buy U.K. biotech company Silence Therapeutics for $1.3 billion, adding an experimental medicine for rare disease polycythemia vera to its drug pipeline. Merck…

More from 4 other outlets

From the 4Search news index, newest first.

In the news

49mentions in 30 days
47with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 49 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance